IMRN Stock Analysis: Buy, Sell, or Hold?
IMRN - Immuron Limited American Depositary Shares
$0.84
-0.06 (-6.61%)
▼
5d:
-11.64%
30d:
+5.84%
90d:
-55.72%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 26, 2026
21d
Get Alerted When IMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IMRN is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IMRN is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IMRN is currently trading at $0.84, which is considered slightly low relative to its 30-day fair value range of $0.82 to $1.03.
Technical Outlook: Technically, IMRN is in a strong downtrend. The price is currently testing key support at $0.84. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.58 (+325.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMRN is in a strong downtrend. The price is currently testing key support at $0.84. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.58 (+325.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.82 -
$1.03
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.6%)
- BULLISH: Trading 325.5% below Wall St target ($3.58)
- WARNING: Recommendation downgraded due to -11.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.82 -
$1.03
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.84
Resistance Level
$1.05
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-42.93
Wall Street Target
$3.58
(+325.5%)
Revenue Growth (YoY)
29.3%
Profit Margin
-71.6%
Last updated: February 04, 2026 2:06 AM ET
Data refreshes hourly during market hours. Next update: 3:06 AM
Data refreshes hourly during market hours. Next update: 3:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
